Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past 24 hours
    • Any time
    • Past hour
    • Past 7 days
    • Past 30 days
5h

Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in ...

Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Walmart CEO to retire
Sues to block CA House map
Protesters block entrance
Linked to cancer risk?
Day care teacher released
Wins album of the year
Jim Avila dies
Under Armour splits w/ Curry
John Fetterman hospitalized
Iran seizes oil tanker?
Colorado AD to step down
Rubiales egged by uncle
Massive attack on Kyiv
Launches NASA spacecraft
Apologizes to Trump
Union workers go on strike
US conducts 20th strike
Pack Fire in Mono County
Some agents to get bonuses
Nevada ‘fake electors’ case
US, Argentina trade deal
Defense workers end strike
UK judge finds BHP liable
Alligator rescued in Boston
SoCal evacuation warnings
Proposes adtech changes
Families sue ByHeart
MLS calendar to change
New prosecutor chosen
Fatal bus crash in Stockholm
Feedback
  • Privacy
  • Terms